Evidence map›Paper›PMID 29261695›Full record

ArticlePloS one2017

Comparing the self-perceived quality of life of multimorbid patients and the general population using the EQ-5D-3L.

Alexandra A N'Goran, Anouk Déruaz-Luyet, Dagmar M Haller, Andreas Zeller, Thomas Rosemann, Sven Streit, Lilli Herzig

Abstract readComparative Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Everyday Lives of Middle-Aged Persons with Multimorbidity: A Mixed Methods Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  2. Pooled it
  3. Effect of the OPTIMAL programme on self-management of multimorbidity in primary care: a randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2021
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analysing the impact of complex multimorbidity on health-related quality of life.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandra A N'GoranInstitute of Family Medicine, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0000-0002-7406-8716
Anouk Déruaz-LuyetInstitute of Family Medicine, University of Lausanne, Lausanne, Switzerland.
Dagmar M HallerPrimary Care Unit, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Andreas ZellerCentre for Primary Health Care, University of Basel, Basel, Switzerland.
Thomas RosemannInstitute of Primary Care, University of Zurich, Zurich, Switzerland.
Sven StreitInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Lilli HerzigInstitute of Family Medicine, University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess and compare the self-perceived Health Related Quality of Life (HRQoL) of multimorbid patients and the general population using health utilities (HU) and visual analogue scale (VAS) methods.

methodsWe analyzed data (n = 888) from a national, cross-sectional Swiss study of multimorbid patients recruited in primary care settings. Self-perceived HRQoL was assessed using the EQ-5D-3L instrument, composed of 1) a questionnaire on the five dimensions of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression (EQ-5D dimensions), and 2) a 0-100 (0 = worst- and 100 = best-imaginable health status) VAS. We described the EQ-5D dimensions and VAS and computed HU using a standard pan-European value set. HU and VAS are the two components of the overall HRQoL assessment. We examined the proportions of multimorbid patients reporting problems (moderate/severe) in each EQ-5D dimension, corresponding proportions without problems, and mean HU and VAS values across patient characteristics. To test differences between subgroups, we used chi-square tests for dichotomous outcomes and T-tests (ANOVA if more than two groups) for continuous outcomes. Finally, we compared observed and predicted HU and VAS values.

resultsAll 888 participants answered every EQ-5D item. Mean (SD) HU and VAS values were 0.70 (0.18) and 63.2 (19.2), respectively. HU and VAS were considerably and significantly lower in multimorbid patients than in the general population and were also lower in multimorbid patients below 60 years old and in women. Differences between observed and predicted means (SD) were -0.07 (0.18) for HU and -11.8 (20.3) for VAS.

conclusionsSelf-perceived HRQoL is considerably and significantly affected by multimorbidity. More attention should be given to developing interventions that improve the HRQoL of multimorbid patients, particularly women and those aged below 60 years old.

Indexed as

ComorbidityQuality of LifeSelf ConceptSurveys and QuestionnairesAgedAged, 80 and overFemaleHumansMaleMiddle AgedVisual Analog Scale

Identifiers

PMID29261695
PMCPMC5736180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.